# Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

> **NCT00453115** · PHASE2 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 43 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00453115
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** 2010-05
- **Final completion:** 2011-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453115, "Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00453115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*